Capital Research Global Investors
GEHC icon

Capital Research Global Investors’s GE HealthCare GEHC Stock Holding History

Capital Research Global Investors’s Portfolio GEHC Stock Details GEHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.5B Sell
21,108,753
-4,253,599
-17% -$335M 0.23% 93
2025
Q4 		$2.08B Buy
25,362,352
+389,796
+2% +$30.4M 0.38% 56
2025
Q3 		$1.88B Buy
24,972,556
+4,998,154
+25% +$373M 0.35% 62
2025
Q2 		$1.48B Sell
19,974,402
-31,220,666
-61% -$2.17B 0.3% 76
2025
Q1 		$4.13B Sell
51,195,068
-9,636,936
-16% -$828M 0.9% 29
2024
Q4 		$4.76B Buy
60,832,004
+2,608,066
+4% +$222M 0.98% 25
2024
Q3 		$5.46B Buy
58,223,938
+4,077,152
+8% +$342M 1.14% 20
2024
Q2 		$4.22B Buy
54,146,786
+154,863
+0.3% +$12.6M 0.93% 23
2024
Q1 		$4.91B Buy
53,991,923
+2,647,204
+5% +$220M 1.11% 21
2023
Q4 		$3.97B Buy
51,344,719
+1,401,566
+3% +$98.2M 0.98% 25
2023
Q3 		$3.4B Buy
49,943,153
+373,364
+0.8% +$27.2M 0.94% 28
2023
Q2 		$4.03B Buy
49,569,789
+6,126,007
+14% +$489M 1.08% 22
2023
Q1 		$3.56B Buy
+43,443,782
New +$3.1B 1.02% 23

Other funds holding GEHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Capital Research Global Investors's GEHC Position: Q1 2026 in Review

Capital Research Global Investors reduced its GE HealthCare (GEHC) stake by 17% in Q1 2026, selling an estimated $335M and leaving 21,108,753 shares worth $1.5B. The position accounts for 0.23% of the portfolio, ranked #93.

Capital Research Global Investors first reported a position in GEHC in Q1 2023 and has held it in 13 quarters since. The position peaked at $5.46B in Q3 2024. 1,265 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Capital Research Global Investors held 21,108,753 shares of GE HealthCare worth $1.5B as of Q1 2026.
  • Capital Research Global Investors sold 4,253,599 GE HealthCare shares in Q1 2026, an estimated $335M.
  • GE HealthCare made up 0.23% of Capital Research Global Investors's portfolio in Q1 2026, its #93 holding.
  • Capital Research Global Investors first reported a position in GE HealthCare in Q1 2023 and has held it in 13 quarters since.
  • Capital Research Global Investors's GE HealthCare position peaked at $5.46B in Q3 2024.
  • 1,265 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Capital Research Global Investors's 13F filing for Q1 2026, filed 13 May 2026.